Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques

Virology

Volumn 458-459, Issue 1, 2014, Pages 53-68

  Yen, Po Jen ^a,b   Mefford, Megan E ^a,b   Hoxie, James A ^c   Williams, Kenneth C ^d   Desrosiers, Ronald C ^b   Gabuzda, Dana ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BOSTON COLLEGE   (United States)

Author keywords

Brain; Envelope glycoprotein (Env); Human immunodeficiency virus (HIV); Macrophage tropism; Simian immunodeficiency virus (SIV)

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFECTION; CELL FUSION; CONTROLLED STUDY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN ISOLATION; RHESUS MONKEY; SEQUENCE ANALYSIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL TROPISM; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

BRAIN; ENVELOPE GLYCOPROTEIN (ENV); HUMAN IMMUNODEFICIENCY VIRUS (HIV); MACROPHAGE TROPISM; SIMIAN IMMUNODEFICIENCY VIRUS (SIV);

AMINO ACID SEQUENCE; ANIMALS; GENE EXPRESSION REGULATION, VIRAL; GENETIC VARIATION; HEK293 CELLS; HUMANS; MACACA MULATTA; MACROPHAGES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN CONFORMATION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 84899830383     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.03.024     Document Type: Article

References (89)

1. Alexaki A., Liu Y., Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr. HIV Res. 2008, 6:388-400.
2. Bannert N., Schenten D., Craig S., Sodroski J. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses. J. Virol. 2000, 74:10984-10993.
3. Bissel S.J., Wang G., Bonneh-Barkay D., Starkey A., Trichel A.M., Murphey-Corb M., Wiley C.A. Systemic and brain macrophage infections in relation to the development of simian immunodeficiency virus encephalitis. J. Virol. 2008, 82:5031-5042.
4. Bixby J.G., Laur O., Johnson W.E., Desrosiers R.C. Diversity of envelope genes from an uncloned stock of SIVmac251. AIDS Res. Hum. Retroviruses 2010, 26:1115-1131.
5. Borda J.T., Alvarez X., Kondova I., Aye P., Simon M.A., Desrosiers R.C., Lackner A.A. Cell tropism of simian immunodeficiency virus in culture is not predictive of in vivo tropism or pathogenesis. Am. J. Pathol. 2004, 165:2111-2122.
6. Chackerian B., Rudensey L.M., Overbaugh J. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J. Virol. 1997, 71:7719-7727.
7. Chen B., Vogan E.M., Gong H., Skehel J.J., Wiley D.C., Harrison S.C. Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein. Structure 2005, 13:197-211.
8. Chen B., Vogan E.M., Gong H., Skehel J.J., Wiley D.C., Harrison S.C. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005, 433:834-841.
9. Choi W.S., Collignon C., Thiriart C., Burns D.P., Stott E.J., Kent K.A., Desrosiers R.C. Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity. J. Virol. 1994, 68:5395-5402.
10. Clements J.E., Babas T., Mankowski J.L., Suryanarayana K., Piatak M., Tarwater P.M., Lifson J.D., Zink M.C. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J. Infect. Dis. 2002, 186:905-913.
11. Daniel M.D., Letvin N.L., King N.W., Kannagi M., Sehgal P.K., Hunt R.D., Kanki P.J., Essex M., Desrosiers R.C. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985, 228:1201-1204.
12. Del Prete G.Q., Scarlotta M., Newman L., Reid C., Parodi L.M., Roser J.D., Oswald K., Marx P.A., Miller C.J., Desrosiers R.C., Barouch D.H., Pal R., Piatak M., Chertova E., Giavedoni L.D., O'Connor D.H., Lifson J.D., Keele B.F. Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies. J. Virol. 2013, 87:4584-4595.
13. Dunfee R., Thomas E.R., Gorry P.R., Wang J., Ancuta P., Gabuzda D. Mechanisms of HIV-1 neurotropism. Curr. HIV Res. 2006, 4:267-278.
14. Dunfee R.L., Thomas E.R., Gabuzda D. Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12. Retrovirology 2009, 6:69.
15. Dunfee R.L., Thomas E.R., Wang J., Kunstman K., Wolinsky S.M., Gabuzda D. Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia. Virology 2007, 367:222-234.
16. Edinger A.L., Ahuja M., Sung T., Baxter K.C., Haggarty B., Doms R.W., Hoxie J.A. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. J. Virol. 2000, 74:7922-7935.
17. Edmonson P., Murphey-Corb M., Martin L.N., Delahunty C., Heeney J., Kornfeld H., Donahue P.R., Learn G.H., Hood L., Mullins J.I. Evolution of a simian immunodeficiency virus pathogen. J. Virol. 1998, 72:405-414.
18. Etemad-Moghadam B., Sun Y., Nicholson E.K., Fernandes M., Liou K., Gomila R., Lee J., Sodroski J. Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo. J. Virol. 2000, 74:4433-4440.
19. Fiore J.R., Bjorndal A., Peipke K.A., Di Stefano M., Angarano G., Pastore G., Gaines H., Fenyo E.M., Albert J. The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 1994, 204:297-303.
20. Flaherty M.T., Hauer D.A., Mankowski J.L., Zink M.C., Clements J.E. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J. Virol. 1997, 71:5790-5798.
21. Gaskill P.J., Watry D.D., Burdo T.H., Fox H.S. Development and characterization of positively selected brain-adapted SIV. Virol. J. 2005, 2:44.
22. Gorry P.R., Churchill M., Crowe S.M., Cunningham A.L., Gabuzda D. Pathogenesis of macrophage tropic HIV-1. Curr. HIV Res. 2005, 3:53-60.
23. Gorry P.R., Taylor J., Holm G.H., Mehle A., Morgan T., Cayabyab M., Farzan M., Wang H., Bell J.E., Kunstman K., Moore J.P., Wolinsky S.M., Gabuzda D. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J. Virol. 2002, 76:6277-6292.
24. Haynes B.F., Gilbert P.B., McElrath M.J., Zolla-Pazner S., Tomaras G.D., Alam S.M., Evans D.T., Montefiori D.C., Karnasuta C., Sutthent R., Liao H.X., DeVico A.L., Lewis G.K., Williams C., Pinter A., Fong Y., Janes H., DeCamp A., Huang Y., Rao M., Billings E., Karasavvas N., Robb M.L., Ngauy V., de Souza M.S., Paris R., Ferrari G., Bailer R.T., Soderberg K.A., Andrews C., Berman P.W., Frahm N., De Rosa S.C., Alpert M.D., Yates N.L., Shen X., Koup R.A., Pitisuttithum P., Kaewkungwal J., Nitayaphan S., Rerks-Ngarm S., Michael N.L., Kim J.H Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 2012, 366:1275-1286.
25. Heise C., Miller C.J., Lackner A., Dandekar S. Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J. Infect. Dis. 1994, 169:1116-1120.
26. Heise C., Vogel P., Miller C.J., Halsted C.H., Dandekar S. Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am. J. Pathol. 1993, 142:1759-1771.
27. Ho D.D., Rota T.R., Hirsch M.S. Infection of monocyte/macrophages by human T lymphotropic virus type III. J. Clin. Invest. 1986, 77:1712-1715.
28. Hoxie J.A., Haggarty B.S., Bonser S.E., Rackowski J.L., Shan H., Kanki P.J. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection. J. Virol. 1988, 62:2557-2568.
29. Huang C.C., Tang M., Zhang M.Y., Majeed S., Montabana E., Stanfield R.L., Dimitrov D.S., Korber B., Sodroski J., Wilson I.A., Wyatt R., Kwong P.D. Structure of a V3-containing HIV-1 gp120 core. Science 2005, 310:1025-1028.
30. Igarashi T., Brown C.R., Endo Y., Buckler-White A., Plishka R., Bischofberger N., Hirsch V., Martin M.A. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc. Nat. Acad. Sci. U.S.A. 2001, 98:658-663.
31. Isaacman-Beck J., Hermann E.A., Yi Y., Ratcliffe S.J., Mulenga J., Allen S., Hunter E., Derdeyn C.A., Collman R.G. Heterosexual transmission of human immunodeficiency virus type 1 subtype C: macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J. Virol. 2009, 83:8208-8220.
32. Johnson P.R., Schnepp B.C., Zhang J., Connell M.J., Greene S.M., Yuste E., Desrosiers R.C., Clark K.R. Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. Nat. Med. 2009, 15:901-906.
33. Johnson W.E., Lifson J.D., Lang S.M., Johnson R.P., Desrosiers R.C. Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus. J. Virol. 2003, 77:375-381.
34. Johnson W.E., Morgan J., Reitter J., Puffer B.A., Czajak S., Doms R.W., Desrosiers R.C. A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope. J. Virol. 2002, 76:2075-2086.
35. Johnson W.E., Sanford H., Schwall L., Burton D.R., Parren P.W., Robinson J.E., Desrosiers R.C. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. J. Virol. 2003, 77:9993-10003.
36. Kanki P.J., McLane M.F., King N.W., Letvin N.L., Hunt R.D., Sehgal P., Daniel M.D., Desrosiers R.C., Essex M. Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science 1985, 228:1199-1201.
37. Keele B.F., Estes J.D. Barriers to mucosal transmission of immunodeficiency viruses. Blood 2011, 118:839-846.
38. Keele B.F., Li H., Learn G.H., Hraber P., Giorgi E.E., Grayson T., Sun C., Chen Y., Yeh W.W., Letvin N.L., Mascola J.R., Nabel G.J., Haynes B.F., Bhattacharya T., Perelson A.S., Korber B.T., Hahn B.H., Shaw G.M. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 2009, 206:1117-1134.
39. Kestler H., Kodama T., Ringler D., Marthas M., Pedersen N., Lackner A., Regier D., Sehgal P., Daniel M., King N., et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 1990, 248:1109-1112.
40. King D.F., Siddiqui A.A., Buffa V., Fischetti L., Gao Y., Stieh D., McKay P.F., Rogers P., Ochsenbauer C., Kappes J.C., Arts E.J., Shattock R.J. Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus. J. Virol. 2013, 87:890-899.
41. Kodama T., Mori K., Kawahara T., Ringler D.J., Desrosiers R.C. Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS. J. Virol. 1993, 67:6522-6534.
42. Kornfeld H., Riedel N., Viglianti G.A., Hirsch V., Mullins J.I. Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature 1987, 326:610-613.
43. Kwong P.D., Wyatt R., Sattentau Q.J., Sodroski J., Hendrickson W.A. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J. Virol. 2000, 74:1961-1972.
44. Lee W.R., Syu W.J., Du B., Matsuda M., Tan S., Wolf A., Essex M., Lee T.H. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc. Nat. Acad. Sci. U.S.A. 1992, 89:2213-2217.
45. Letvin N.L., Daniel M.D., Sehgal P.K., Desrosiers R.C., Hunt R.D., Waldron L.M., MacKey J.J., Schmidt D.K., Chalifoux L.V., King N.W. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985, 230:71-73.
46. Li H., Bar K.J., Wang S., Decker J.M., Chen Y., Sun C., Salazar-Gonzalez J.F., Salazar M.G., Learn G.H., Morgan C.J., Schumacher J.E., Hraber P., Giorgi E.E., Bhattacharya T., Korber B.T., Perelson A.S., Eron J.J., Cohen M.S., Hicks C.B., Haynes B.F., Markowitz M., Keele B.F., Hahn B.H., Shaw G.M. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog. 2010, 6:e1000890.
47. Lin G., Simmons G., Pohlmann S., Baribaud F., Ni H., Leslie G.J., Haggarty B.S., Bates P., Weissman D., Hoxie J.A., Doms R.W. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 2003, 77:1337-1346.
48. Liu L., Cimbro R., Lusso P., Berger E.A. Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer. Proc. Nat. Acad. Sci. U.S.A. 2011, 108:20148-20153.
49. Louder M.K., Sambor A., Chertova E., Hunte T., Barrett S., Ojong F., Sanders-Buell E., Zolla-Pazner S., McCutchan F.E., Roser J.D., Gabuzda D., Lifson J.D., Mascola J.R. HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity. Virology 2005, 339:226-238.
50. Luciw P.A., Shaw K.E., Unger R.E., Planelles V., Stout M.W., Lackner J.E., Pratt-Lowe E., Leung N.J., Banapour B., Marthas M.L. Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). AIDS Res. Hum. Retroviruses 1992, 8:395-402.
51. Marcon L., Sodroski J. High degree of sensitivity of the simian immunodeficiency virus (SIVmac) envelope glycoprotein subunit association to amino acid changes in the glycoprotein 41 ectodomain. AIDS Res. Hum. Retroviruses 1997, 13:441-447.
52. McLellan J.S., Pancera M., Carrico C., Gorman J., Julien J.P., Khayat R., Louder R., Pejchal R., Sastry M., Dai K., O'Dell S., Patel N., Shahzad-ul-Hussan S., Yang Y., Zhang B., Zhou T., Zhu J., Boyington J.C., Chuang G.Y., Diwanji D., Georgiev I., Kwon Y.D., Lee D., Louder M.K., Moquin S., Schmidt S.D., Yang Z.Y., Bonsignori M., Crump J.A., Kapiga S.H., Sam N.E., Haynes B.F., Burton D.R., Koff W.C., Walker L.M., Phogat S., Wyatt R., Orwenyo J., Wang L.X., Arthos J., Bewley C.A., Mascola J.R., Nabel G.J., Schief W.R., Ward A.B., Wilson I.A., Kwong P.D. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 2011, 480:336-343.
53. Means R.E., Matthews T., Hoxie J.A., Malim M.H., Kodama T., Desrosiers R.C. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4. J. Virol. 2001, 75:3903-3915.
54. Miller C.J., Marthas M., Greenier J., Lu D., Dailey P.J., Lu Y. in vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. J. Virol. 1998, 72:3248-3258.
55. Mori K., Ringler D.J., Kodama T., Desrosiers R.C. Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J. Virol. 1992, 66:2067-2075.
56. Mori K., Rosenzweig M., Desrosiers R.C. Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages. J. Virol. 2000, 74:10852-10859.
57. Musich T., Peters P.J., Duenas-Decamp M.J., Gonzalez-Perez M.P., Robinson J., Zolla-Pazner S., Ball J.K., Luzuriaga K., Clapham P.R. A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection. J. Virol. 2011, 85:2397-2405.
58. Naidu Y.M., Kestler H.W., Li Y., Butler C.V., Silva D.P., Schmidt D.K., Troup C.D., Sehgal P.K., Sonigo P., Daniel M.D., et al. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol. 1988, 62:4691-4696.
59. Ochsenbauer C., Edmonds T.G., Ding H., Keele B.F., Decker J., Salazar M.G., Salazar-Gonzalez J.F., Shattock R., Haynes B.F., Shaw G.M., Hahn B.H., Kappes J.C. Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J. Virol. 2012, 86:2715-2728.
60. Ogert R.A., Lee M.K., Ross W., Buckler-White A., Martin M.A., Cho M.W. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J. Virol. 2001, 75:5998-6006.
61. Orandle M.S., MacLean A.G., Sasseville V.G., Alvarez X., Lackner A.A. Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis. J. Virol. 2002, 76:5797-5802.
62. Otto C., Puffer B.A., Pohlmann S., Doms R.W., Kirchhoff F. Mutations in the C3 region of human and simian immunodeficiency virus envelope have differential effects on viral infectivity, replication, and CD4-dependency. Virology 2003, 315:292-302.
63. Pantophlet R., Burton D.R. GP120: target for neutralizing HIV-1 antibodies. Annu. Rev. Immunol. 2006, 24:739-769.
64. Pikora C., Wittish C., Desrosiers R.C. Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4. J. Virol. 2005, 79:12575-12583.
65. Pinter A., Honnen W.J., He Y., Gorny M.K., Zolla-Pazner S., Kayman S.C. The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. J. Virol. 2004, 78:5205-5215.
66. Puffer B.A., Pohlmann S., Edinger A.L., Carlin D., Sanchez M.D., Reitter J., Watry D.D., Fox H.S., Desrosiers R.C., Doms R.W. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J. Virol. 2002, 76:2595-2605.
67. Rizzuto C.D., Wyatt R., Hernandez-Ramos N., Sun Y., Kwong P.D., Hendrickson W.A., Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998, 280:1949-1953.
68. Rolland M., Edlefsen P.T., Larsen B.B., Tovanabutra S., Sanders-Buell E., Hertz T., deCamp A.C., Carrico C., Menis S., Magaret C.A., Ahmed H., Juraska M., Chen L., Konopa P., Nariya S., Stoddard J.N., Wong K., Zhao H., Deng W., Maust B.S., Bose M., Howell S., Bates A., Lazzaro M., O'Sullivan A., Lei E., Bradfield A., Ibitamuno G., Assawadarachai V., O'Connell R.J., deSouza M.S., Nitayaphan S., Rerks-Ngarm S., Robb M.L., McLellan J.S., Georgiev I., Kwong P.D., Carlson J.M., Michael N.L., Schief W.R., Gilbert P.B., Mullins J.I., Kim J.H. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature 2012, 490:417-420.
69. Rud E.W., Cranage M., Yon J., Quirk J., Ogilvie L., Cook N., Webster S., Dennis M., Clarke B.E. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J. Gen. Virol. 1994, 75(3):529-543.
70. Rusert P., Krarup A., Magnus C., Brandenberg O.F., Weber J., Ehlert A.K., Regoes R.R., Gunthard H.F., Trkola A. Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies. J. Exp. Med. 2011, 208:1419-1433.
71. Ryzhova E., Aye P., Harvey T., Cao W., Lackner A., Gonzalez-Scarano F. Intrathecal humoral responses are inversely associated with the frequency of simian immunodeficiency virus macrophage-tropic variants in the central nervous system. J. Virol. 2009, 83:8282-8288.
72. Ryzhova E., Whitbeck J.C., Canziani G., Westmoreland S.V., Cohen G.H., Eisenberg R.J., Lackner A., Gonzalez-Scarano F. Rapid progression to simian AIDS can be accompanied by selection of CD4-independent gp120 variants with impaired ability to bind CD4. J. Virol. 2002, 76:7903-7909.
73. Ryzhova E.V., Crino P., Shawver L., Westmoreland S.V., Lackner A.A., Gonzalez-Scarano F. Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples. Virology 2002, 297:57-67.
74. Sagar M., Wu X., Lee S., Overbaugh J. Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J. Virol. 2006, 80:9586-9598.
75. Salazar-Gonzalez J.F., Salazar M.G., Keele B.F., Learn G.H., Giorgi E.E., Li H., Decker J.M., Wang S., Baalwa J., Kraus M.H., Parrish N.F., Shaw K.S., Guffey M.B., Bar K.J., Davis K.L., Ochsenbauer-Jambor C., Kappes J.C., Saag M.S., Cohen M.S., Mulenga J., Derdeyn C.A., Allen S., Hunter E., Markowitz M., Hraber P., Perelson A.S., Bhattacharya T., Haynes B.F., Korber B.T., Hahn B.H., Shaw G.M. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 2009, 206:1273-1289.
76. Sawyer L.S., Wrin M.T., Crawford-Miksza L., Potts B., Wu Y., Weber P.A., Alfonso R.D., Hanson C.V. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 1994, 68:1342-1349.
77. Schuitemaker H., Koot M., Kootstra N.A., Dercksen M.W., de Goede R.E., van Steenwijk R.P., Lange J.M., Schattenkerk J.K., Miedema F., Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 1992, 66:1354-1360.
78. Schuitemaker H., Kootstra N.A., de Goede R.E., de Wolf F., Miedema F., Tersmette M. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 1991, 65:356-363.
79. Smith P.D., Meng G., Salazar-Gonzalez J.F., Shaw G.M. Macrophage HIV-1 infection and the gastrointestinal tract reservoir. J. Leukoc. Biol. 2003, 74:642-649.
80. Strickland S.L., Gray R.R., Lamers S.L., Burdo T.H., Huenink E., Nolan D.J., Nowlin B., Alvarez X., Midkiff C.C., Goodenow M.M., Williams K., Salemi M. Significant genetic heterogeneity of the SIVmac251 viral swarm derived from different sources. AIDS Res. Hum. Retroviruses 2011.
81. Sullivan N., Sun Y., Sattentau Q., Thali M., Wu D., Denisova G., Gershoni J., Robinson J., Moore J., Sodroski J. CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 1998, 72:4694-4703.
82. Tremblay M.J., Fortin J.F., Cantin R. The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today 1998, 19:346-351.
83. Willey R.L., Shibata R., Freed E.O., Cho M.W., Martin M.A. Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures. J. Virol. 1996, 70:6431-6436.
84. Williams K., Schwartz A., Corey S., Orandle M., Kennedy W., Thompson B., Alvarez X., Brown C., Gartner S., Lackner A. Proliferating cellular nuclear antigen expression as a marker of perivascular macrophages in simian immunodeficiency virus encephalitis. Am. J. Pathol. 2002, 161:575-585.
85. Williams K.C., Corey S., Westmoreland S.V., Pauley D., Knight H., deBakker C., Alvarez X., Lackner A.A. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J. Exp. Med. 2001, 193:905-915.
86. Wyatt R., Moore J., Accola M., Desjardin E., Robinson J., Sodroski J. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J. Virol. 1995, 69:5723-5733.
87. Yen P.J., Herschhorn A., Haim H., Salas I., Gu C., Sodroski J., Gabuzda D. Loss of a conserved N-linked glycosylation site in the SIV envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission. J. Virol. 2014, 88:5014-5028.
88. Zhu T., Mo H., Wang N., Nam D.S., Cao Y., Koup R.A., Ho D.D. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993, 261:1179-1181.
89. Zink M.C., Suryanarayana K., Mankowski J.L., Shen A., Piatak M., Spelman J.P., Carter D.L., Adams R.J., Lifson J.D., Clements J.E. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J. Virol. 1999, 73:10480-10488.